Global glycoproteins market set to grow to USD 700.6 million by 2033 with CAGR of 3.28%

From GlobeNewswire: 2024-07-12 08:00:00

The Global Glycoproteins Market is set to grow from USD 507.3 Million in 2023 to USD 700.6 Million by 2033, with a CAGR of 3.28%. Glycoproteins play a crucial role in the immune system and are used in various sectors including vaccine development. The lack of expertise in healthcare may hinder market growth.

The N-linkage segment is expected to dominate the global glycoproteins market, with applications in biotechnology, pharmaceuticals, and diagnostics. The research institutes segment is projected to grow rapidly due to its focus on new applications and developments. North America is forecasted to hold the largest market share, driven by biotechnology advancements.

Asia Pacific is anticipated to be the fastest-growing region in the glycoproteins market, driven by the expanding pharmaceutical sector. Key players in the market include Enzo Life Sciences, R&D Systems, and Thermo Fisher Scientific. Recent developments include R&D Systems launching recombinant glycoproteins for research use.

Research conducted by Spherical Insights & Consulting forecasts revenue growth in the global glycoproteins market up to 2033. The market is segmented based on product type, application, and region. Other related reports include the Global Iron Phosphate Market, Polymer Blends Alloys Market, and Water Desalination Equipment Market, providing insights into various industries. Contact Spherical Insights for more information and market analysis.



Read more at GlobeNewswire: Global Glycoproteins Market Size To Worth USD 700.6 Million